Verona Pharma

News

Verona shareholders back $10bn MSD takeover

MSD has moved a step closer to completing its acquisition of Verona Pharma, after a vote in favour of the transaction by the UK firm's shareholders.

News

Update: MSD confirms $10bn takeover deal for Verona Pharma

MSD has agreed a $10bn takeover offer for respiratory drug specialist Verona Pharma and its fast-growing COPD therapy Ohtuvayre.

News

Scrabble letters spelling out 'Deep Breath'

Verona says COPD drug is off to a flying start

Verona Pharma's plans to transform COPD treatment with recently approved Ohtuvayre look like they are on course, given early sales figures.

News

GSK says Nucala hits the target in new COPD trial

GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial.<

News

Verona’s first-in-class COPD drug ‘could transform market’

Verona Pharma has claimed FDA approval for its chronic obstructive pulmonary disease (COPD) drug ensifentrine, which has been tipped as a future blockbuster.

News

Verona cuts $400m loan deal as it preps COPD drug for market

Verona Pharma has agreed a new $400 million debt facility with Oxford Finance and Hercules Capital designed to help the company navigate the possible approval and launch o

Verona shareholders back $10bn MSD takeover

Update: MSD confirms $10bn takeover deal for Verona Pharma

Verona says COPD drug is off to a flying start

GSK says Nucala hits the target in new COPD trial

Verona’s first-in-class COPD drug ‘could transform market’

Verona cuts $400m loan deal as it preps COPD drug for market

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Verona Pharma

Editor's Picks